This new plain language summary in Future Rare Diseases discusses a study using data from the MPS I Registry that looks at the age when individuals were diagnosed with MPS I and the time taken for them to start treatment with enzyme replacement therapy or hematopoietic stem cell transplantation.

Read the full article here.

The original article on which this summary is based is called ‘Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I’ and was originally published in the journal Archives of Disease in Childhood. The original article can be read here.